Some patients report a temporary 23 pound rebound in the first 2 weeks due to appetite rebound, but this stabilizes once semaglutide doses increase
The ApoB-100:ApoA-1 ratio is a strong predictor of cardiovascular risk, particularly in overweight and obese individuals
Long-Term Outlook (3-5 Years) However, looking out 35 years, we see a favourable risk profile
In addition to supporting weight management, semaglutide improves blood sugar control and insulin sensitivity, promoting better overall health
Anjum NA, Sharma P, Gill SS, Hasanuzzaman M, Khan EA, Kachhap K, Mohamed AA, Thangavel P, Devi GD, Vasudhevan P, Sofo A, Khan NA, Misra AN, Lukatkin AS, Singh HP, Pereira E, Tuteja N (2016) Catalase and ascorbate peroxidaserepresentative H2O2-detoxifying heme enzymes in plants
Regular monitoring and communication with your healthcare provider ensure the medication continues to work safely and effectively